SR9009 Inhibits Lethal Prostate Cancer Subtype 1 by Regulating the LXRα/FOXM1 Pathway Independently of REV-ERBs

The authors found that SR9009 was specifically lethal to prostate cancer (PCa) cell lines but had no cytotoxic effect on prostate cells. SR9009 significantly inhibited colony formation, the cell cycle, and cell migration and promoted apoptosis in PCa cells.
[Cell Death & Disease]
Full Article

Stay up-to-date with your field!

Subscribe for free weekly science newsletters.

Related News